BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Mannan R, Xiao L, Abdulfatah E, Qiao Y, Farver C, Myers JL, Zelenka-wang S, Mcmurry L, Su F, Wang R, Pantanowitz L, Jentzen J, Wilson A, Zhang Y, Cao X, Chinnaiyan AM, Mehra R. Characterization of SARS-CoV-2 and host entry factors distribution in a COVID-19 autopsy series. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00025-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Colombo D, Del Nonno F, Marchioni L, Lalle E, Gallì P, Vaia F, Falasca L. Autopsies Revealed Pathological Features of COVID-19 in Unvaccinated vs. Vaccinated Patients. Biomedicines 2023;11. [PMID: 36831087 DOI: 10.3390/biomedicines11020551] [Reference Citation Analysis]
2 Bellavite P, Ferraresi A, Isidoro C. Immune Response and Molecular Mechanisms of Cardiovascular Adverse Effects of Spike Proteins from SARS-CoV-2 and mRNA Vaccines. Biomedicines 2023;11. [PMID: 36830987 DOI: 10.3390/biomedicines11020451] [Reference Citation Analysis]
3 Rudraraju R, Gartner MJ, Neil JA, Stout ES, Chen J, Needham EJ, See M, Mackenzie-kludas C, Yang Lee LY, Wang M, Pointer H, Karavendzas K, Abu-bonsrah D, Drew D, Sun YBY, Tan JP, Sun G, Salavaty A, Charitakis N, Nim HT, Currie PD, Tham W, Porrello E, Polo J, Humphrey SJ, Ramialison M, Elliott DA, Subbarao K. Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2.. [DOI: 10.1101/2022.09.20.508614] [Reference Citation Analysis]
4 Korobova ZR, Arsentieva NA, Liubimova NE, Dedkov VG, Gladkikh AS, Sharova AA, Chernykh EI, Kashchenko VA, Ratnikov VA, Gorelov VP, Stanevich OV, Kulikov AN, Pevtsov DE, Totolian AA. A Comparative Study of the Plasma Chemokine Profile in COVID-19 Patients Infected with Different SARS-CoV-2 Variants. Int J Mol Sci 2022;23:9058. [PMID: 36012323 DOI: 10.3390/ijms23169058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fang Y, Zhang L, Wang Z, Wang R, Liang S. Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis. Front Pharmacol 2022;13:969709. [PMID: 36034788 DOI: 10.3389/fphar.2022.969709] [Reference Citation Analysis]
6 Kohli A, Sauerhering L, Fehling SK, Klann K, Geiger H, Becker S, Koch B, Baer PC, Strecker T, Münch C. Proteomic landscape of SARS-CoV-2– and MERS-CoV–infected primary human renal epithelial cells. Life Sci Alliance 2022;5:e202201371. [DOI: 10.26508/lsa.202201371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rein T. Harnessing autophagy to fight SARS-CoV-2: An update in view of recent drug development efforts. J Cell Biochem 2021. [PMID: 34668225 DOI: 10.1002/jcb.30166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]